There is another factor to consider with medications that are taken in the long term.I have no idea if this is the case with Trofinetide and maybe the company doesn’t know yet either but drug ‘tolerance’ can occur where the effect of a specific dose diminishes with time requiring an increase dose to maintain the same affect.
A question to pose to Jon at a later date which could influence revenues in the long term
- Forums
- ASX - By Stock
- NEU
- Ann: Investor Presentation, 14 March 2023
Ann: Investor Presentation, 14 March 2023, page-46
-
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.45 |
Change
-0.070(0.34%) |
Mkt cap ! $2.613B |
Open | High | Low | Value | Volume |
$20.60 | $20.77 | $20.32 | $3.866M | 188.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 237 | $20.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.49 | 1026 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2633 | 20.380 |
3 | 1467 | 20.360 |
1 | 1033 | 20.350 |
2 | 1853 | 20.340 |
1 | 828 | 20.320 |
Price($) | Vol. | No. |
---|---|---|
20.490 | 1026 | 2 |
20.550 | 2289 | 3 |
20.560 | 639 | 2 |
20.570 | 631 | 3 |
20.590 | 828 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online